RECOVERY OF THE RAT HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AFTER DISCONTINUATION OF PROLONGED TREATMENT WITH THE SYNTHETIC GLUCOCORTICOID AGONIST DEXAMETHASONE

被引:38
作者
CALOGERO, AE
KAMILARIS, TC
JOHNSON, EO
TARTAGLIA, ME
CHROUSOS, G
机构
[1] Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
关键词
D O I
10.1210/endo-127-4-1574
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the recovery of the hypothalamicpituitary- adrenal (HPA) axis after discontinuation of prolonged exposure to glucocorticoids, we employed adult male Sprague- Dawley rats which were implanted sc with osmotic minipumps filled with saline (vehicle) or dexamethasone (DEX), 100 μg/ day, for 7 days. At the end of the glucocorticoid treatment period, the minipumps were removed and both saline- and DEX-treated rats were randomly assigned to five different groups tested at 1, 3, 7, 14, and 21 days after removal of the minipumps. Each group was divided into two subgroups receiving either arecoline (ARE), or ovine CRH (oCRH) stimulation tests. ARE was chosen because it has been shown to selectively stimulate the hypothalamic CRH neuron, whereas oCRH was selected as a probe of the pituitary component of the HPA axis. ARE (0.2 mg/kg) and oCRH (10 μg/kg) were injected iv to catheterized, freely moving rats and serial blood samples for plasma ACTH and corticosterone determinations were drawn from the catheter before, and 5, 15, 30, and 60 min after the injection. The day after the tests were performed, the rats were killed by decapitation, and body, adrenal and thymus weights, as well as hypothalamic CRH and pituitary ACTH content were determined. On the day of the stimulation tests, basal plasma levels of ACTH and corticosterone were not different between saline- and DEX-treated rats at any time-point after discontinuation of treatment. The ACTH response to ARE, on the other hand, was suppressed one day after, but became normal 3 days after discontinuation of DEX treatment. ACTH response to oCRH normalized later, after 7 days. Interestingly, corticosterone responses to both ARE and oCRH normalized 7 days after discontinuation of glucocorticoid administration. Body, adrenal and thymus weights were significantly reduced by DEX treatment. They recovered slowly and only after 22 days there was no difference between DEX- and saline-treated rats in body and adrenal weight. In contrast, thymus weight was still low on day 8, began to increase after 15 days, and by day 22 did not reach the values recorded in salinetreated rats. Hypothalamic immunoreactive CRH content was not different between DEX- and saline-treated rats, whereas the content of ACTH in the pituitary gland was lower in the DEXtreated rats the second day after discontinuation of GC treatment, normalized after 4 days and increased significantly after 8 days. These results suggest that in the rat, prolonged treatment with DEX reduces the ability of each component of the HPA axis to respond to an appropriate stimulus. This reduction is transient. Normalization of the hypothalamus occurs by the third day and of the pituitary gland and the adrenal cortex by the seventh day. This sequence of events is distinctly different from that which has been proposed in human beings. © 1990 by The Endocrine Society.
引用
收藏
页码:1574 / 1579
页数:6
相关论文
共 26 条
  • [1] THE CORTICOTROPIN-RELEASING HORMONE TEST IN THE POSTOPERATIVE EVALUATION OF PATIENTS WITH CUSHINGS-SYNDROME
    AVGERINOS, PC
    CHROUSOS, GP
    NIEMAN, LK
    OLDFIELD, EH
    LORIAUX, DL
    CUTLER, GB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (05) : 906 - 913
  • [2] SEROTONIN AGONISTS CAUSE PARALLEL ACTIVATION OF THE SYMPATHOADRENOMEDULLARY SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL AXIS IN CONSCIOUS RATS
    BAGDY, G
    CALOGERO, AE
    MURPHY, DL
    SZEMEREDI, K
    [J]. ENDOCRINOLOGY, 1989, 125 (05) : 2664 - 2669
  • [3] EFFECTS OF SEROTONERGIC AGONISTS AND ANTAGONISTS ON CORTICOTROPIN-RELEASING HORMONE-SECRETION BY EXPLANTED RAT HYPOTHALAMI
    CALOGERO, AE
    BERNARDINI, R
    MARGIORIS, AN
    BAGDY, G
    GALLUCCI, WT
    MUNSON, PJ
    TAMARKIN, L
    TOMAI, TP
    BRADY, L
    GOLD, PW
    CHROUSOS, GP
    [J]. PEPTIDES, 1989, 10 (01) : 189 - 200
  • [4] MULTIPLE FEEDBACK REGULATORY LOOPS UPON RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE-SECRETION - POTENTIAL CLINICAL IMPLICATIONS
    CALOGERO, AE
    GALLUCCI, WT
    GOLD, PW
    CHROUSOS, GP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (03) : 767 - 774
  • [5] THE MUSCARINIC CHOLINERGIC AGONIST ARECOLINE STIMULATES THE RAT HYPOTHALAMIC-PITUITARY-ADRENAL AXIS THROUGH A CENTRALLY-MEDIATED CORTICOTROPIN-RELEASING HORMONE-DEPENDENT MECHANISM
    CALOGERO, AE
    KAMILARIS, TC
    GOMEZ, MT
    JOHNSON, EO
    TARTAGLIA, ME
    GOLD, PW
    CHROUSOS, GP
    [J]. ENDOCRINOLOGY, 1989, 125 (05) : 2445 - 2453
  • [6] EFFECTS OF DEXAMETHASONE ON CENTRAL AND PERIPHERAL ACTH SYSTEMS IN THE RAT
    CARNES, M
    BARKSDALE, CM
    KALIN, NH
    BROWNFIELD, MS
    LENT, SJ
    [J]. NEUROENDOCRINOLOGY, 1987, 45 (02) : 160 - 164
  • [7] EFFECTS OF CORTICOSTEROIDS ON HYPOTHALAMIC CORTICOTROPIN RELEASING FACTOR AND PITUITARY ACTH CONTENT
    CHOWERS, I
    CONFORTI, N
    FELDMAN, S
    [J]. NEUROENDOCRINOLOGY, 1967, 2 (04) : 193 - &
  • [8] THE CORTICOTROPIN-RELEASING FACTOR STIMULATION TEST - AN AID IN THE EVALUATION OF PATIENTS WITH CUSHINGS-SYNDROME
    CHROUSOS, GP
    SCHULTE, HM
    OLDFIELD, EH
    GOLD, PW
    CUTLER, GB
    LORIAUX, DL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (10) : 622 - 626
  • [9] CLINICAL-APPLICATIONS OF CORTICOTROPIN-RELEASING FACTOR
    CHROUSOS, GP
    SCHUERMEYER, TH
    DOPPMAN, J
    OLDFIELD, EH
    SCHULTE, HM
    GOLD, PW
    LORIAUX, DL
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) : 344 - 358
  • [10] CHROUSOS GP, 1988, CONNS CURRENT THERAP, P525